CIK 0001833214
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853899721
- Phone
- +1 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- S-4/A Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- S-4/A Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- S-4 Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure · Other events
Page 5 of 6 · 107 filings